Akero Therapeutics, Inc. - COM (AKRO)

Historical Portfolio Holders from Q2 2019 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
72.6 M
Holdings value Q1 2024
$1.83 B
Value change Q1 2024
+$381 M
Grand Portfolio weight change Q1 2024
+0.001%
Number of holders
164
Number of buys Q1 2024
105
Number of sells Q1 2024
-59
Average buys Q1 2024 %
+0.002%
Average sells Q1 2024 %
-0.001%
CUSIP
00973Y108
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 72.6 M $1.83 B +$381 M $25.26 166
2023 Q4 57.1 M $1.33 B -$172 M $23.35 152
2023 Q3 56.5 M $2.86 B +$62.9 M $50.58 180
2023 Q2 56.2 M $2.62 B +$390 M $46.69 153
2023 Q1 47.9 M $1.83 B -$63.2 M $38.26 153
2022 Q4 48.5 M $2.66 B +$143 M $54.80 156
2022 Q3 46.3 M $1.58 B +$488 M $34.05 141
2022 Q2 34.6 M $327 M -$12 M $9.45 101
2022 Q1 35 M $496 M -$4.32 M $14.19 93
2021 Q4 35.2 M $744 M +$3.82 M $21.15 91
2021 Q3 28 M $626 M +$6.66 M $22.35 101
2021 Q2 25.7 M $638 M -$131 M $24.81 93
2021 Q1 31.5 M $913 M +$20.6 M $29.01 107
2020 Q4 30.8 M $813 M +$45.3 M $25.80 91
2020 Q3 29 M $892 M +$220 M $30.79 98
2020 Q2 21.8 M $544 M -$5.68 M $24.92 73
2020 Q1 21.7 M $460 M +$62.8 M $21.20 63
2019 Q4 19 M $422 M +$18.2 M $22.19 56
2019 Q3 12.7 M $288 M +$54.8 M $22.75 53
2019 Q2 10.7 M $205 M +$205 M $19.15 48